{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:29:23Z","timestamp":1790803763325,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL141539"],"award-info":[{"award-number":["K23HL141539"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01HL092870"],"award-info":[{"award-number":["P01HL092870"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL141539"],"award-info":[{"award-number":["K23HL141539"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01HL092870"],"award-info":[{"award-number":["P01HL092870"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Relatives of patients with familial pulmonary fibrosis (FPF) are at increased risk to develop FPF. Interstitial lung abnormalities (ILAs) are a radiologic biomarker of subclinical disease, but the implications of very mild abnormalities remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To quantify the progression risk among FPF relatives with abnormalities below the threshold for ILAs as described by the Fleischner Society and to describe the characteristics of participants with new or progressive ILAs during observation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Asymptomatic FPF relatives undergo serial screening high-resolution chest computed tomography. For this analysis, early ILAs (no minimum threshold of lung involvement) were subclassified as mild (all interstitial abnormalities involve &amp;lt;5% of a lung zone) or moderate (any abnormality involves &amp;gt;5%). Identification of new or progressive ILAs on high-resolution chest computed tomography and the development of pulmonologist-diagnosed clinical FPF were defined as progression. Covariate-adjusted logistic regression identified progression-associated characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>From 2008 to 2023, 273 participants in follow-up procedures were 53.2\u2009\u00b1\u20099.4 years of age at enrollment, 95 (35%) were men, and 73 of 268 (27%) were ever-smokers. During a mean follow-up period of 6.2\u2009\u00b1\u20093.0 years, progression occurred among 31 of 211 (15%) of those with absence of ILAs at enrollment, 32 of 49 (65%) of those with mild ILAs, and 10 of 13 (77%) of those with moderate ILAs. Subjects with mild ILAs had 9.15 (95% confidence interval, 4.40\u201319.00; P\u2009&amp;lt;\u20090.0001) times and those with moderate ILAs had 17.14 (95% confidence interval, 4.42\u201366.49; P\u2009&amp;lt;\u20090.0001) times the odds of progression as subjects without ILAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In persons at risk for FPF, minor interstitial abnormalities, including reticulation that is unilateral or involves &amp;lt;5% of a lung zone, frequently represent subclinical disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202403-0524oc","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:10:16Z","timestamp":1723561816000},"page":"1441-1452","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":24,"title":["Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study"],"prefix":"10.1093","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-6955","authenticated-orcid":false,"given":"Margaret L.","family":"Salisbury","sequence":"first","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Markin","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tisra","family":"Fadely","sequence":"additional","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Guttentag","sequence":"additional","affiliation":[{"name":"Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-4530","authenticated-orcid":false,"given":"Stephen M.","family":"Humphries","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Jewish Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lynch","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Jewish Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8923-1344","authenticated-orcid":false,"given":"Jonathan A.","family":"Kropski","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee"},{"name":"U.S. Department of Veterans Affairs Medical Center, Nashville, Tennessee; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0337-7052","authenticated-orcid":false,"given":"Timothy S.","family":"Blackwell","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee"},{"name":"U.S. Department of Veterans Affairs Medical Center, Nashville, Tennessee; and"},{"name":"Department of Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,15]]},"reference":[{"key":"2026022020442954400_bib1","doi-asserted-by":"crossref","first-page":"180077","DOI":"10.1183\/16000617.0077-2018","article-title":"The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype","volume":"27","author":"Olson","year":"2018","journal-title":"Eur Respir Rev"},{"key":"2026022020442954400_bib2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2213-2600(14)70101-8","article-title":"Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001\u201311","volume":"2","author":"Raghu","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026022020442954400_bib3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026022020442954400_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1513\/AnnalsATS.201912-880OC","article-title":"Antifibrotic drug use in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry","volume":"17","author":"Salisbury","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2026022020442954400_bib5","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"2026022020442954400_bib6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"2026022020442954400_bib7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1513\/AnnalsATS.202303-188PS","article-title":"Approach to clinical trials for the prevention of pulmonary fibrosis","volume":"20","author":"Kim","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2026022020442954400_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","article-title":"Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner Society","volume":"8","author":"Hatabu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026022020442954400_bib9","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1056\/NEJMoa1216076","article-title":"MUC5B promoter polymorphism and interstitial lung abnormalities","volume":"368","author":"Hunninghake","year":"2013","journal-title":"N Engl J Med"},{"key":"2026022020442954400_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.2016.0518","article-title":"Association between interstitial lung abnormalities and all-cause mortality","volume":"315","author":"Putman","year":"2016","journal-title":"JAMA"},{"key":"2026022020442954400_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12931-023-02359-9","article-title":"Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis","volume":"24","author":"Patel","year":"2023","journal-title":"Respir Res"},{"key":"2026022020442954400_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201809-1652OC","article-title":"Imaging patterns are associated with interstitial lung abnormality progression and mortality","volume":"200","author":"Putman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib13","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1164\/rccm.201512-2523OC","article-title":"Development and progression of interstitial lung abnormalities in the Framingham Heart Study","volume":"194","author":"Araki","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01950-2022","article-title":"Incidence of interstitial lung abnormalities: the MESA Lung Study","author":"McGroder","year":"2023","journal-title":"Eur Respir J"},{"key":"2026022020442954400_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/rccm.202204-0781OC","article-title":"The genetic landscape of familial pulmonary fibrosis","volume":"207","author":"Liu","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1164\/rccm.201909-1834OC","article-title":"Development and progression of radiologic abnormalities in individuals at risk for familial interstitial lung disease","volume":"201","author":"Salisbury","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib17","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.rmed.2011.08.022","article-title":"Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis","volume":"105","author":"Garc\u00eda-Sancho","year":"2011","journal-title":"Respir Med"},{"key":"2026022020442954400_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1164\/rccm.202206-1075OC","article-title":"Incidence and progression of fibrotic lung disease in an at-risk cohort","volume":"207","author":"Steele","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.201406-1162OC","article-title":"Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease","volume":"191","author":"Kropski","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib20","first-page":"A7213","article-title":"Interstitial lung abnormalities below fleischner-defined thresholds are strongly associated with progression in persons at risk for familial pulmonary fibrosis [abstract]","volume":"209","author":"Salisbury","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/thoraxjnl-2018-212430","article-title":"MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis","volume":"74","author":"Mathai","year":"2019","journal-title":"Thorax"},{"key":"2026022020442954400_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1148\/radiol.2017161177","article-title":"Idiopathic pulmonary fibrosis: data-driven textural analysis of extent of fibrosis at baseline and 15-month follow-up","volume":"285","author":"Humphries","year":"2017","journal-title":"Radiology"},{"key":"2026022020442954400_bib23","doi-asserted-by":"crossref","first-page":"1801384","DOI":"10.1183\/13993003.01384-2018","article-title":"Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis","volume":"52","author":"Humphries","year":"2018","journal-title":"Eur Respir J"},{"key":"2026022020442954400_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.chest.2022.06.030","article-title":"Quantitative interstitial abnormality progression and outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study cohorts","volume":"163","author":"Choi","year":"2023","journal-title":"Chest"},{"key":"2026022020442954400_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.chest.2023.01.012","article-title":"Radiographic lung abnormalities in first-degree relatives of patients with different subtypes of pulmonary fibrosis","volume":"163","author":"McGroder","year":"2023","journal-title":"Chest"},{"key":"2026022020442954400_bib27","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","article-title":"Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive","volume":"48","author":"Newton","year":"2016","journal-title":"Eur Respir J"},{"key":"2026022020442954400_bib28","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1164\/rccm.201908-1571OC","article-title":"Interstitial lung disease in relatives of patients with pulmonary fibrosis","volume":"201","author":"Hunninghake","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.202208-1470LE","article-title":"Progressive interstitial lung disease in relatives of patients with pulmonary fibrosis","volume":"207","author":"Rose","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022020442954400_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pulmoe.2022.09.002","article-title":"Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients","volume":"29","author":"Lucas","year":"2023","journal-title":"Pulmonology"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/210\/12\/1441\/66997273\/ajrccm_210_12_1441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/210\/12\/1441\/66997273\/ajrccm_210_12_1441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:44:37Z","timestamp":1771638277000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/210\/12\/1441\/8491361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,15]]},"published-print":{"date-parts":[[2024,12,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202403-0524oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}